DMKN Human 1,2-dimethylhydrazine increases expression ISO Dmkn (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of DMKN mRNA CTD PMID:22206623 DMKN Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DMKN mRNA CTD PMID:20106945 and PMID:21632981 DMKN Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dmkn (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DMKN mRNA CTD PMID:21570461 DMKN Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Dmkn (Mus musculus) 6480464 2 more ... CTD PMID:38648751 DMKN Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DMKN mRNA CTD PMID:28628672 DMKN Human 4-hydroxyphenyl retinamide increases expression ISO Dmkn (Mus musculus) 6480464 Fenretinide results in increased expression of DMKN mRNA CTD PMID:28973697 DMKN Human 6-propyl-2-thiouracil decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of DMKN mRNA CTD PMID:24780913 DMKN Human 6-propyl-2-thiouracil multiple interactions ISO Dmkn (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMKN mRNA CTD PMID:36706583 DMKN Human acrylamide affects expression ISO Dmkn (Rattus norvegicus) 6480464 Acrylamide affects the expression of DMKN mRNA CTD PMID:28959563 DMKN Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of DMKN mRNA CTD PMID:22100608 DMKN Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of DMKN gene CTD PMID:27153756 DMKN Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DMKN mRNA CTD PMID:22100608 DMKN Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of DMKN mRNA CTD PMID:33212167 DMKN Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DMKN mRNA CTD PMID:32525701 DMKN Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DMKN mRNA CTD PMID:32525701 DMKN Human benzo[a]pyrene decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of DMKN mRNA CTD PMID:21839799 DMKN Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of DMKN promoter CTD PMID:27901495 DMKN Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of DMKN mRNA CTD PMID:38218311 DMKN Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of DMKN mRNA CTD PMID:38218311 DMKN Human bilirubin IXalpha decreases expression EXP 6480464 Bilirubin results in decreased expression of DMKN mRNA CTD PMID:20196124 DMKN Human bisphenol A affects expression ISO Dmkn (Rattus norvegicus) 6480464 bisphenol A affects the expression of DMKN mRNA CTD PMID:25181051 DMKN Human bisphenol A increases expression ISO Dmkn (Mus musculus) 6480464 bisphenol A results in increased expression of DMKN mRNA CTD PMID:32156529 DMKN Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DMKN gene CTD PMID:31601247 DMKN Human bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DMKN gene CTD PMID:31601247 DMKN Human bisphenol A decreases expression ISO Dmkn (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of DMKN mRNA CTD PMID:34947998 DMKN Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DMKN mRNA CTD PMID:27685785 DMKN Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of DMKN mRNA CTD PMID:26079696 DMKN Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of DMKN mRNA CTD PMID:23369406 DMKN Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of DMKN mRNA CTD PMID:38382870 DMKN Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of DMKN mRNA CTD PMID:26485663 DMKN Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of DMKN mRNA CTD PMID:25979313 DMKN Human carbon nanotube affects expression ISO Dmkn (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of DMKN mRNA CTD PMID:25554681 DMKN Human carbon nanotube increases expression ISO Dmkn (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of DMKN mRNA CTD PMID:25554681 DMKN Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to DMKN gene] CTD PMID:28238834 DMKN Human chloroprene increases expression ISO Dmkn (Mus musculus) 6480464 Chloroprene results in increased expression of DMKN mRNA CTD PMID:23125180 DMKN Human chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of DMKN protein CTD PMID:28596144 DMKN Human copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of DMKN mRNA CTD PMID:38568856 DMKN Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of DMKN mRNA CTD PMID:19549813 DMKN Human crocidolite asbestos increases expression ISO Dmkn (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of DMKN mRNA CTD PMID:23917077 DMKN Human crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of DMKN mRNA CTD PMID:29523930 DMKN Human Cuprizon increases expression ISO Dmkn (Rattus norvegicus) 6480464 Cuprizone results in increased expression of DMKN mRNA CTD PMID:26577399 DMKN Human Cuprizon decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of DMKN mRNA CTD PMID:27523638 DMKN Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of DMKN mRNA CTD PMID:27989131 DMKN Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of DMKN mRNA CTD PMID:25047013 DMKN Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DMKN mRNA CTD PMID:28628672 DMKN Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of DMKN mRNA CTD PMID:37042841 DMKN Human diiodine multiple interactions ISO Dmkn (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMKN mRNA CTD PMID:36706583 DMKN Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMKN mRNA CTD PMID:27188386 DMKN Human ethyl methanesulfonate decreases expression EXP 6480464 Ethyl Methanesulfonate results in decreased expression of DMKN mRNA CTD PMID:23649840 DMKN Human folic acid decreases expression ISO Dmkn (Mus musculus) 6480464 Folic Acid results in decreased expression of DMKN mRNA CTD PMID:25629700 DMKN Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DMKN gene CTD PMID:31601247 DMKN Human genistein affects expression ISO Dmkn (Mus musculus) 6480464 Genistein affects the expression of DMKN mRNA CTD PMID:32186404 DMKN Human gentamycin decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of DMKN mRNA CTD PMID:33387578 DMKN Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DMKN mRNA CTD PMID:28628672 DMKN Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DMKN mRNA CTD PMID:35811015 DMKN Human manganese(II) chloride increases expression ISO Dmkn (Rattus norvegicus) 6480464 manganese chloride results in increased expression of DMKN mRNA CTD PMID:28801915 DMKN Human methamphetamine increases expression ISO Dmkn (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of DMKN mRNA CTD PMID:19564919 DMKN Human methamphetamine decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Methamphetamine results in decreased expression of DMKN mRNA CTD PMID:32035215 DMKN Human methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of DMKN mRNA CTD PMID:23649840 DMKN Human N,N-diethyl-m-toluamide multiple interactions ISO Dmkn (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of DMKN gene CTD PMID:33148267 DMKN Human ozone multiple interactions ISO Dmkn (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DMKN mRNA CTD PMID:34911549 DMKN Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DMKN mRNA CTD PMID:26690555 DMKN Human paracetamol decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of DMKN mRNA CTD PMID:33387578 DMKN Human pentanal increases expression EXP 6480464 pentanal results in increased expression of DMKN mRNA CTD PMID:26079696 DMKN Human perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of DMKN mRNA CTD PMID:27153767 DMKN Human permethrin multiple interactions ISO Dmkn (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of DMKN gene CTD PMID:33148267 DMKN Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DMKN mRNA CTD PMID:19710929 DMKN Human pirinixic acid increases expression ISO Dmkn (Mus musculus) 6480464 pirinixic acid results in increased expression of DMKN mRNA CTD PMID:20813756 DMKN Human propanal increases expression EXP 6480464 propionaldehyde results in increased expression of DMKN mRNA CTD PMID:26079696 DMKN Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of DMKN mRNA CTD PMID:25888808 DMKN Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMKN mRNA CTD PMID:23557933 DMKN Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DMKN mRNA CTD PMID:35811015 DMKN Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMKN mRNA CTD PMID:27188386 DMKN Human SCH 23390 decreases expression ISO Dmkn (Rattus norvegicus) 6480464 SCH 23390 results in decreased expression of DMKN mRNA CTD PMID:19564919 DMKN Human silicon dioxide increases expression ISO Dmkn (Mus musculus) 6480464 Silicon Dioxide results in increased expression of DMKN mRNA CTD PMID:23221170 DMKN Human silicon dioxide increases expression ISO Dmkn (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of DMKN mRNA CTD PMID:34779285 DMKN Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DMKN mRNA CTD PMID:32525701 DMKN Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of DMKN mRNA CTD PMID:29301061 and PMID:32844245 DMKN Human sodium arsenite decreases expression ISO Dmkn (Mus musculus) 6480464 sodium arsenite results in decreased expression of DMKN mRNA CTD PMID:37682722 DMKN Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of DMKN mRNA CTD PMID:38568856 DMKN Human sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of DMKN intron CTD PMID:32844245 DMKN Human sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DMKN mRNA CTD PMID:36139627 DMKN Human sulforaphane increases expression ISO Dmkn (Mus musculus) 6480464 sulforaphane results in increased expression of DMKN mRNA CTD PMID:30529165 DMKN Human titanium dioxide increases expression ISO Dmkn (Mus musculus) 6480464 titanium dioxide results in increased expression of DMKN mRNA CTD PMID:19464567 DMKN Human titanium dioxide affects expression ISO Dmkn (Mus musculus) 6480464 titanium dioxide affects the expression of DMKN mRNA CTD PMID:23557971 DMKN Human trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DMKN mRNA CTD PMID:36139627 DMKN Human trichloroethene decreases expression ISO Dmkn (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of DMKN mRNA CTD PMID:33387578 DMKN Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMKN mRNA CTD PMID:27188386 DMKN Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of DMKN mRNA CTD PMID:37042841 DMKN Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of DMKN mRNA CTD PMID:29024780 DMKN Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of DMKN mRNA CTD PMID:29453283 DMKN Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of DMKN mRNA CTD PMID:28818685 DMKN Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of DMKN mRNA CTD PMID:23527032 DMKN Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of DMKN mRNA CTD PMID:28001369 DMKN Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of DMKN mRNA CTD PMID:25979313 DMKN Human valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of DMKN gene CTD PMID:29154799 DMKN Human vinclozolin increases expression ISO Dmkn (Rattus norvegicus) 6480464 vinclozolin results in increased expression of DMKN mRNA CTD PMID:22570695